Visualization of therapeutic intervention for acute liver injury using low-intensity pulsed ultrasound-responsive phase variant nanoparticles
Source abstract
Abstract
Acute liver injury (ALI) is a highly fatal condition characterized by sudden massive necrosis of liver cells, inflammation, and impaired coagulation function. Currently, the primary clinical approach for managing ALI involves symptom management based on the underlying causes. The association between excessive reactive oxygen species originating from macrophages and acute liver injury is noteworthy. Therefore, we designed a novel nanoscale phase variant contrast agent, denoted as PFP@CeO2@Lips, which effectively scavenges reactive oxygen species, and enables visualization through low intensity pulsed ultrasound activation. The efficacy of the nanoparticles in scavenging excess reactive oxygen species from RAW264.7 and protective AML12 cells has been demonstrated through in vitro and in vivo experiments. Additionally, these nanoparticles have shown a protective effect against LPS/D-GalN attack in C57BL/6J mice. Furthermore, when exposed to LIPUS irritation, the nanoparticles undergo liquid-gas phase transition and enable ultrasound imaging.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Ultrasound and Hyperthermia Applications · Spectroscopy Techniques in Biomedical and Chemical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Ultrasound, Affifiliated Hospital of North Sichuan Medical College, Innovation Centre for Science and Technology of North Sichuan Medical College, Nanchong, 637000, Sichuan, China
Department of Radiology, Affifiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China
Department of Ultrasound, Yuechi People's Hospital, Guangan, 638300, Sichuan, China
Funding
Bureau of Science and Technology Nanchong Municipality
References (45)
Show source-provided references
1. Vento · Lancet · 2020 · 395 · 183310.1016/S0140-6736(20)30046-5 ↗
2. Younossi · Clin. Gastroenterol. Hepatol. · 2023 · 21 · 197810.1016/j.cgh.2023.04.015 ↗
3. Xiao · J. Hepatol. · 2019 · 71 · 21210.1016/j.jhep.2019.03.004 ↗
4. Br · Clin. Mol. Hepatol. · 2023 · 29 · 67010.3350/cmh.2022.0103 ↗
5. Devarbhavi · J. Hepatol. · 2023 · 79 · 51610.1016/j.jhep.2023.03.017 ↗
6. Schwabe · Nat. Rev. Gastroenterol. Hepatol. · 2018 · 15 · 73810.1038/s41575-018-0065-y ↗
7. Stravitz · Lancet · 2019 · 394 · 86910.1016/S0140-6736(19)31894-X ↗
8. Kulkarni · Clin. Liver Dis. · 2023 · 27 · 73510.1016/j.cld.2023.03.015 ↗
9. Xu · J. Hepatol. · 2022 · 77 · 34410.1016/j.jhep.2022.02.024 ↗
10. Shan · Front. Immunol. · 2020 · 11 · 32210.3389/fimmu.2020.00322 ↗
11. Volarevic · ACS Nano · 2014 · 8 · 1209810.1021/nn502466z ↗
12. Yang · Chem. Rev. · 2019 · 119 · 488110.1021/acs.chemrev.8b00626 ↗
13. Ma · Adv. Mater. · 2020 · 32 · e200306510.1002/adma.202003065 ↗
14. Zhao · Adv. Mater. · 2021 · 33 · e210239110.1002/adma.202102391 ↗
15. Chen · Biomater. Sci. · 2023 · 11 · 234810.1039/D2BM01968J ↗
16. Wu · Adv. Sci. · 2022 · e210398210.1002/advs.202103982 ↗
17. Montini · Chem. Rev. · 2016 · 116 · 598710.1021/acs.chemrev.5b00603 ↗
18. Casals · Antioxidants · 2021 · 10 · 66010.3390/antiox10050660 ↗
19. Wu · Int. J. Nanomed. · 2020 · 15 · 251510.2147/IJN.S246783 ↗
20. Yang · Adv. Mater. · 2019 · 31 · e190177810.1002/adma.201901778 ↗
21. Li · Biomaterials · 2022 · 291 · 12190410.1016/j.biomaterials.2022.121904 ↗
22. Zhang · ACS Appl. Mater. Interfaces · 2020 · 12 · 5683010.1021/acsami.0c17579 ↗
23. Boey · Int. J. Mol. Sci. · 2021 · 22 · 1177710.3390/ijms222111777 ↗
24. König · Trends Pharmacol. Sci. · 2017 · 38 · 110.1016/j.tips.2016.11.004 ↗
25. Qiu · Photoacoustics · 2023 · 31 · 10051110.1016/j.pacs.2023.100511 ↗
26. Rowe · CA-Cancer J. Clin. · 2022 · 72 · 33310.3322/caac.21713 ↗
27. van de Donk · J. Immunother. Cancer · 2022 · 10 · e00494910.1136/jitc-2022-004949 ↗
28. Yoon · IEEE Trans. Ultrason. Eng. Freq. Control · 2018 · 65 · 227710.1109/TUFFC.2018.2829740 ↗
29. Fan · Theranostics · 2021 · 11 · 267010.7150/thno.53083 ↗
30. Sun · Stem Cell Res. Ther. · 2020 · 11 · 14510.1186/s13287-020-01655-1 ↗
31. Jiang · IEEE Trans. Biomed. Eng. · 2019 · 66 · 270410.1109/TBME.2018.2889669 ↗
32. Bottger · Adv. Drug Delivery Rev. · 2020 · 154–155 · 7910.1016/j.addr.2020.06.017 ↗
33. Oro · J. Hepatol. · 2016 · 64 · 69110.1016/j.jhep.2015.10.020 ↗
34. Cafun · ACS Nano · 2013 · 7 · 1072610.1021/nn403542p ↗
35. Yang · J. Biomed. Nanotechnol. · 2022 · 18 · 281810.1166/jbn.2022.3485 ↗
36. Gao · Nanoscale · 2021 · 13 · 533310.1039/D0NR06878K ↗
37. Liu · Langmuir · 2016 · 32 · 1327610.1021/acs.langmuir.6b03342 ↗
38. Xie · Nanoscale · 2018 · 10 · 1281310.1039/C8NR02605J ↗
39. Zhu · Mol. Pharm. · 2020 · 17 · 81710.1021/acs.molpharmaceut.9b01070 ↗
40. Aliabouzar · J. Acoust. Soc. Am. · 2018 · 143 · 200110.1121/1.5027817 ↗
41. Karakoti · J. Am. Chem. Soc. · 2009 · 131 · 1414410.1021/ja9051087 ↗
42. Abbas · Expert Rev. Gastroenterol. Hepatol. · 2022 · 16 · 63910.1080/17474124.2022.2097070 ↗
43. Bajaj · Am. J. Gastroenterol. · 2022 · 117 · 22510.14309/ajg.0000000000001595 ↗
44. Liu · Mater. Today Bio · 2022 · 13 · 10021510.1016/j.mtbio.2022.100215 ↗
45. Chen · Front. Chem. · 2020 · 8 · 73210.3389/fchem.2020.00732 ↗